
Jacobson Pharma Corporation Limited, through its subsidiaries, engages in the development, production, marketing, and sale of essential medicines and specialty drugs in Hong Kong, Mainland China, Macau, and internationally. The company offers a portfolio of generic drugs for various therapeutic classes, such as cardiovascular, central nervous, gastrointestinal, respiratory, musculo-skeletal, genito-urinary, anti-infectives, endocrine and metabolic, dermatologicals, and anti-allergics in oral solid and liquid, external liquid, semi-solid, sterile, rectal, and specialized forms. It also provides management and treasury services. Jacobson Pharma Corporation Limited was incorporated in 2016 and is headquartered in Kwun Tong, Hong Kong.